人肝细胞癌中异常超级增强子景观
该研究系统比较正常肝脏与肝细胞癌(HCC)细胞的超级增强子(SE)景观,发现HCC中顺式SE景观广泛重编程,多个癌基因获得SE驱动高表达;反式SE复合体组分CDK7、BRD4、EP300和MED1在HCC中常过表达且与不良预后相关;HCC细胞对SE复合体扰动高度敏感,CDK7抑制剂THZ1在体外和体内HCC模型中均显示抗癌效果。
要点
- HCC细胞中顺式SE景观广泛重编程,多个癌基因获得SE驱动高表达。
- SE复合体组分CDK7、BRD4、EP300和MED1在HCC中常过表达且与不良预后相关。
- CDK7抑制剂THZ1在体外和体内HCC模型中均显示抗癌效果。
核心结论
- HCC中SE景观和SE复合体显著改变,HCC细胞对SE复合体扰动高度敏感,靶向SE复合体是HCC治疗的有前景策略。
研究设计与样本
- 研究系统比较正常肝脏与HCC细胞的SE景观,并使用CRISPR/Cas9基因编辑系统和小分子抑制剂进行功能验证。
主要发现
- HCC细胞在多个显著癌基因处获得SE以驱动其强表达,SPHK1被鉴定为SE相关癌基因。
- SE复合体关键组分CDK7、BRD4、EP300和MED1在人类HCC中频繁过表达,并与患者不良预后相关。
- HCC细胞对SE复合体扰动高度敏感,CDK7、BRD4、EP300和MED1失活选择性抑制HCC中SE相关癌基因表达。
- CDK7小分子抑制剂THZ1在体外和体内HCC模型中均发挥显著抗癌效果。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hepatocellular carcinoma (HCC) cells exploit an aberrant transcriptional program to sustain their infinite growth and progression. Emerging evidence indicates that the continuous and robust transcription of oncogenes in cancer cells is often driven by super-enhancers (SEs). In this study, we systematically compared the SE landscapes between normal liver and HCC cells and revealed that the cis-acting SE landscape was extensively reprogrammed during liver carcinogenesis. HCC cells acquired SEs at multiple prominent oncogenes to drive their vigorous expression. We identified sphingosine kinase 1 (SPHK1) as an SE-associated oncogene, and we used this gene as an example to illustrate the impact of SEs on the activation of oncogenes in HCC. Concurrently, we also showed that the critical components of the trans-acting SE complex, namely, cyclin-dependent kinase 7 (CDK7), bromodomain-containing protein 4 (BRD4), E1A binding protein P300 (EP300), and mediator complex subunit 1 (MED1), were frequently overexpressed in human HCCs and were associated with the poor prognosis of patients with HCC. Using the CRISPR/Cas9 gene-editing system and specific small-molecule inhibitors, we further demonstrated that HCC cells were highly sensitive to perturbations of the SE complex. The inactivation of CDK7, BRD4, EP300, and MED1 selectively repressed the expression of SE-associated oncogenes in HCC. Finally, we demonstrated that THZ1, which is a small-molecule inhibitor of CDK7, exerted a prominent anticancer effect in both in vitro and in vivo HCC models. Conclusion: The SE landscape and machinery were significantly altered in human HCCs. HCC cells are highly susceptible to perturbations of the SE complex due to the resulting selective suppression of SE-associated oncogenes. Our results suggest that targeting SE complex is a promising therapeutic strategy for HCC treatment.
引用
- Tsang FH, Law CT, Tang TC, et al. Aberrant Super-Enhancer Landscape in Human Hepatocellular Carcinoma. Hepatology. 2019. PMID: 30723918. doi:10.1002/hep.30544
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。